5 Best Performing Biotech Stocks in 2023

4. Ambrx Biopharma Inc. (NASDAQ:AMAM)

Year To Date Share Price Gains: 336.47%

Ambrx Biopharma Inc. (NASDAQ:AMAM) is a biotechnology firm that seeks to leverage the human immune system in the fight against cancer. The firm shared data in October 2023 for a drug that targets prostate cancer which outlined no adverse reactions and a significant reduction prostate specific antigens (PSAs).

During Q2 2023, 15 among the 910 hedge funds surveyed by Insider Monkey were the firm’s investors. Ambrx Biopharma Inc. (NASDAQ:AMAM)’s biggest investor is Abhishek Trehan’s Darwin Global Management due to its $274 million investment.

Follow Ambrx Biopharma Inc.